CNPAX
Price
$72.99
Change
-$0.98 (-1.32%)
Updated
Jul 13 closing price
Net Assets
170.23B
ENTIX
Price
$18.99
Change
-$0.17 (-0.89%)
Updated
Jul 13 closing price
Net Assets
43.96M
Interact to see
Advertisement

CNPAX vs ENTIX

CNPAX vs ENTIX Comparison Chart in %
View a ticker or compare two or three
VS
CNPAX vs. ENTIX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Hold and ENTIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 170B vs. ENTIX (44M). CNPAX pays higher dividends than ENTIX: CNPAX (0.95) vs ENTIX (0.05). CNPAX was incepted earlier than ENTIX: CNPAX (24 years) vs ENTIX (16 years). ENTIX (1.30) is less costly to investors than CNPAX (0.74). ENTIX is a more actively managed with annual turnover of: 82.00 vs. CNPAX (23.00). CNPAX has a lower initial minimum investment than ENTIX: CNPAX (250) vs ENTIX (2500). CNPAX annual gain was more profitable for investors over the last year : 7.37 vs. ENTIX (0.15). CNPAX return over 5 years is better than : 13.82 vs. ENTIX (-6.22).
CNPAXENTIXCNPAX / ENTIX
Total Expense Ratio0.740.9876%
Annual Report Gross Expense Ratio0.741.3057%
Fund Existence24 years16 years-
Gain YTD5.325-4.091-130%
Front Load4%N/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets170B44M386,364%
Annual Yield % from dividends0.950.052,105%
Returns for 1 year7.370.154,950%
Returns for 3 years34.1761.8155%
Returns for 5 years13.82-6.22-222%
Returns for 10 years115.9157.60201%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FBDIX200.49N/A
N/A
Franklin Biotechnology Discovery A
VGHCX206.44N/A
N/A
Vanguard Health Care Inv
SCETX9.22N/A
N/A
Virtus Ceredex Small-Cap Value Eq I
SEFCX14.37N/A
N/A
SEI International Equity Y (SIT)
VREMX7.87N/A
N/A
Virtus SGA Emerging Markets Equity R6